Key Updates in Diabetes From AHA 2023 Key Updates in Diabetes From AHA 2023

Highlights in diabetes from AHA 2023 include a meta-analysis of the DAPA-HF and DELIVER trials, therapeutic effects of SGLT2 inhibitors, and the lag in uptake of this therapy in the clinical setting.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news